Literature DB >> 20336153

Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Karsten Sauer1, Michael P Cooke.   

Abstract

The membrane lipid phosphatidylinositol-3,4,5-trisphosphate (PtdInsP(3)) regulates membrane receptor signalling in many cells, including immunoreceptor signalling. Here, we review recent data that have indicated essential roles for the soluble PtdInsP(3) analogue inositol-1,3,4,5-tetrakisphosphate (InsP(4)) in T cell, B cell and neutrophil development and function. Decreased InsP(4) production in leukocytes causes immunodeficiency in mice and might contribute to inflammatory vasculitis in Kawasaki disease in humans. InsP(4)-producing kinases could therefore provide attractive drug targets for inflammatory and infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336153      PMCID: PMC2922113          DOI: 10.1038/nri2745

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  138 in total

1.  Signal transduction. Unexpected mediators of protein phosphorylation.

Authors:  John D York; Tony Hunter
Journal:  Science       Date:  2004-12-17       Impact factor: 47.728

2.  Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice.

Authors:  K Jun; G Choi; S G Yang; K Y Choi; H Kim; G C Chan; D R Storm; C Albert; G W Mayr; C J Lee; H S Shin
Journal:  Learn Mem       Date:  1998 Sep-Oct       Impact factor: 2.460

3.  The diversity and possible functions of the inositol polyphosphate 5-phosphatases.

Authors:  C Erneux; C Govaerts; D Communi; X Pesesse
Journal:  Biochim Biophys Acta       Date:  1998-12-08

4.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

5.  A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export.

Authors:  J D York; A R Odom; R Murphy; E B Ives; S R Wente
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

6.  Inositol 1,3,4,5-tetrakisphosphate enhances long-term potentiation by regulating Ca2+ entry in rat hippocampus.

Authors:  C Szinyei; T Behnisch; G Reiser; K G Reymann
Journal:  J Physiol       Date:  1999-05-01       Impact factor: 5.182

7.  Distinct subcellular localisations of the putative inositol 1,3,4,5-tetrakisphosphate receptors GAP1IP4BP and GAP1m result from the GAP1IP4BP PH domain directing plasma membrane targeting.

Authors:  P J Lockyer; J R Bottomley; J S Reynolds; T J McNulty; K Venkateswarlu; B V Potter; C E Dempsey; P J Cullen
Journal:  Curr Biol       Date:  1997-12-01       Impact factor: 10.834

8.  A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains.

Authors:  L E Rameh; A k Arvidsson; K L Carraway; A D Couvillon; G Rathbun; A Crompton; B VanRenterghem; M P Czech; K S Ravichandran; S J Burakoff; D S Wang; C S Chen; L C Cantley
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

9.  Inhibition of phosphatases and increased Ca2+ channel activity by inositol hexakisphosphate.

Authors:  O Larsson; C J Barker; A Sjöholm; H Carlqvist; R H Michell; A Bertorello; T Nilsson; R E Honkanen; G W Mayr; J Zwiller; P O Berggren
Journal:  Science       Date:  1997-10-17       Impact factor: 47.728

10.  The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.

Authors:  X Pesesse; C Moreau; A L Drayer; R Woscholski; P Parker; C Erneux
Journal:  FEBS Lett       Date:  1998-10-23       Impact factor: 4.124

View more
  43 in total

Review 1.  Defining signal transduction by inositol phosphates.

Authors:  Stephen B Shears; Sindura B Ganapathi; Nikhil A Gokhale; Tobias M H Schenk; Huanchen Wang; Jeremy D Weaver; Angelika Zaremba; Yixing Zhou
Journal:  Subcell Biochem       Date:  2012

Review 2.  Impact of dietary components on NK and Treg cell function for cancer prevention.

Authors:  Young S Kim; Thomas J Sayers; Nancy H Colburn; John A Milner; Howard A Young
Journal:  Mol Carcinog       Date:  2015-04-01       Impact factor: 4.784

3.  Functionally significant metabolic differences between B and T lymphocyte lineages.

Authors:  Jasneet Kaur Khalsa; Amanpreet Singh Chawla; Savit B Prabhu; Mukti Vats; Atika Dhar; Gagan Dev; Nabanita Das; Sandip Mukherjee; Shalini Tanwar; Hridesh Banerjee; Jeannine Marie Durdik; Vineeta Bal; Anna George; Satyajit Rath; Gopalakrishnan Aneeshkumar Arimbasseri
Journal:  Immunology       Date:  2019-08-26       Impact factor: 7.397

4.  Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese children.

Authors:  Ho-Chang Kuo; Ying-Jui Lin; Suh-Hang Hank Juo; Yu-Wen Hsu; Wei-Chiao Chen; Kuender D Yang; Chi-Di Liang; Shengyu Yang; Mei-Chyn Chao; Hong-Ren Yu; Shouyan Wang; Li-Yan Lin; Wei-Chiao Chang
Journal:  J Clin Immunol       Date:  2011-04-13       Impact factor: 8.317

5.  IP3 3-kinase B controls hematopoietic stem cell homeostasis and prevents lethal hematopoietic failure in mice.

Authors:  Sabine Siegemund; Stephanie Rigaud; Claire Conche; Blake Broaten; Lana Schaffer; Luise Westernberg; Steven Robert Head; Karsten Sauer
Journal:  Blood       Date:  2015-03-18       Impact factor: 22.113

6.  Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.

Authors:  Govindarajan Thangavelu; Jing Du; Katelyn G Paz; Michael Loschi; Michael C Zaiken; Ryan Flynn; Patricia A Taylor; Andrew Kemal Kirchmeier; Angela Panoskaltsis-Mortari; Leo Luznik; Kelli P MacDonald; Geoffrey R Hill; Ivan Maillard; David H Munn; Jonathan S Serody; William J Murphy; David Miklos; Corey S Cutler; John Koreth; Joseph H Antin; Robert J Soiffer; Jerome Ritz; Carol Dahlberg; Andrew T Miller; Bruce R Blazar
Journal:  Blood       Date:  2020-01-02       Impact factor: 22.113

7.  Inositol polyphosphates promote T cell-independent humoral immunity via the regulation of Bruton's tyrosine kinase.

Authors:  Wooseob Kim; Eunha Kim; Hyungyu Min; Min Gyu Kim; Verena B Eisenbeis; Amit K Dutta; Igor Pavlovic; Henning J Jessen; Seyun Kim; Rho Hyun Seong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-12       Impact factor: 11.205

Review 8.  Relevance of solute carrier family 5 transporter defects to inherited and acquired human disease.

Authors:  Miryam Cannizzaro; Jana Jarošová; Boel De Paepe
Journal:  J Appl Genet       Date:  2019-07-08       Impact factor: 3.240

9.  SnapShot: Inositol phosphates.

Authors:  Ace J Hatch; John D York
Journal:  Cell       Date:  2010-12-10       Impact factor: 41.582

10.  Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk.

Authors:  Dale L Phelps; Robert M Ward; Rick L Williams; Kristi L Watterberg; Abbot R Laptook; Lisa A Wrage; Tracy L Nolen; Timothy R Fennell; Richard A Ehrenkranz; Brenda B Poindexter; C Michael Cotten; Mikko K Hallman; Ivan D Frantz; Roger G Faix; Kristin M Zaterka-Baxter; Abhik Das; M Bethany Ball; T Michael O'Shea; Conra Backstrom Lacy; Michele C Walsh; Seetha Shankaran; Pablo J Sánchez; Edward F Bell; Rosemary D Higgins
Journal:  Pediatr Res       Date:  2013-09-04       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.